Ryouichi Horie

2.6k total citations
73 papers, 2.0k citations indexed

About

Ryouichi Horie is a scholar working on Immunology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Ryouichi Horie has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 27 papers in Pathology and Forensic Medicine and 24 papers in Cancer Research. Recurrent topics in Ryouichi Horie's work include Lymphoma Diagnosis and Treatment (24 papers), T-cell and Retrovirus Studies (23 papers) and NF-κB Signaling Pathways (22 papers). Ryouichi Horie is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), T-cell and Retrovirus Studies (23 papers) and NF-κB Signaling Pathways (22 papers). Ryouichi Horie collaborates with scholars based in Japan, United States and Australia. Ryouichi Horie's co-authors include Toshiki Watanabe, Masaaki Higashihara, Mariko Watanabe, Kazuo Umezawa, Takaomi Ishida, Kinji Ito, Marshall E. Kadin, Kinji Itoh, Shigemi Aizawa and Jun‐ichiro Inoue and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Ryouichi Horie

72 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryouichi Horie Japan 25 929 700 599 570 565 73 2.0k
Masaaki Higashihara Japan 25 542 0.6× 618 0.9× 675 1.1× 269 0.5× 477 0.8× 127 2.1k
Junichi Kameoka Japan 22 722 0.8× 469 0.7× 730 1.2× 240 0.4× 1.3k 2.3× 88 2.4k
Mitsuru Tsudo Japan 27 2.1k 2.3× 402 0.6× 532 0.9× 168 0.3× 862 1.5× 75 3.1k
Shigeki Shimizu Japan 29 457 0.5× 262 0.4× 1.0k 1.7× 481 0.8× 1.4k 2.5× 108 3.5k
Angela Gradilone Italy 31 361 0.4× 292 0.4× 754 1.3× 1.1k 1.9× 1.9k 3.3× 83 2.8k
Philippe Ruminy France 26 363 0.4× 1.2k 1.7× 535 0.9× 441 0.8× 779 1.4× 91 2.1k
Richard Gedrich United States 23 878 0.9× 187 0.3× 1.5k 2.5× 685 1.2× 601 1.1× 42 2.5k
Kensuke Kojima Japan 29 327 0.4× 320 0.5× 1.8k 2.9× 283 0.5× 1.1k 1.9× 135 2.9k
A F Gazdar United States 16 302 0.3× 114 0.2× 707 1.2× 186 0.3× 573 1.0× 20 1.6k
M Stetler-Stevenson United States 22 735 0.8× 677 1.0× 680 1.1× 330 0.6× 869 1.5× 44 2.3k

Countries citing papers authored by Ryouichi Horie

Since Specialization
Citations

This map shows the geographic impact of Ryouichi Horie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryouichi Horie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryouichi Horie more than expected).

Fields of papers citing papers by Ryouichi Horie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryouichi Horie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryouichi Horie. The network helps show where Ryouichi Horie may publish in the future.

Co-authorship network of co-authors of Ryouichi Horie

This figure shows the co-authorship network connecting the top 25 collaborators of Ryouichi Horie. A scholar is included among the top collaborators of Ryouichi Horie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryouichi Horie. Ryouichi Horie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakashima, Makoto, Atae Utsunomiya, Toshiki Watanabe, Ryouichi Horie, & Kaoru Uchimaru. (2022). The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma. Cancer Science. 114(4). 1556–1568. 5 indexed citations
2.
Satoh, Takashi, Haruki Uojima, Makoto Kubo, et al.. (2022). B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis. Annals of Hematology. 101(11). 2433–2444. 1 indexed citations
3.
Wada, Naohisa, Haruki Uojima, Takashi Satoh, et al.. (2020). Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease. Digestive Diseases. 39(3). 234–242. 7 indexed citations
4.
Uojima, Haruki, Yoshitaka Arase, Norio Itokawa, et al.. (2018). Relationship between response to lusutrombopag and splenic volume. World Journal of Gastroenterology. 24(46). 5271–5279. 18 indexed citations
5.
Watanabe, Mariko, Kazumi Nakano, Marshall E. Kadin, et al.. (2016). CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells. American Journal Of Pathology. 187(1). 163–175. 3 indexed citations
6.
Watanabe, Mariko, Kinji Itoh, Tomiteru Togano, et al.. (2011). Ets-1 Activates Overexpression of JunB and CD30 in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma. American Journal Of Pathology. 180(2). 831–838. 24 indexed citations
7.
Yoshida, Tsutomu, Naoya Nakamura, Sabine Kajita, et al.. (2010). CD3- and CD4-Positive Plasmablastic Lymphoma: A Literature Review of Japanese Plasmablastic Lymphoma Cases. Internal Medicine. 49(16). 1801–1805. 31 indexed citations
8.
Miyake, Ariko, Md. Zahidunnabi Dewan, Takaomi Ishida, et al.. (2008). Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-κB inhibitor DHMEQ. Microbes and Infection. 10(7). 748–756. 18 indexed citations
9.
Watanabe, Mariko, Makoto Nakashima, Tomiteru Togano, et al.. (2008). Identification of the RelA domain responsible for action of a new NF-κB inhibitor DHMEQ. Biochemical and Biophysical Research Communications. 376(2). 310–314. 32 indexed citations
10.
Horie, Ryouichi, Takaomi Ishida, Kinji Ito, et al.. (2007). TRAF activation of C/EBPβ (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages. Microbes and Infection. 9(6). 721–728. 24 indexed citations
11.
Ohsugi, Takeo, Toshio Kumasaka, Seiji Okada, et al.. (2007). Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with Tax-deficient adult T-cell leukemia-derived cell lines. Cancer Letters. 257(2). 206–215. 23 indexed citations
12.
Horie, Ryouichi. (2007). NF-κB in Pathogenesis and Treatment of Adult T-Cell Leukemia/Lymphoma. International Reviews of Immunology. 26(5-6). 269–281. 17 indexed citations
13.
Dewan, Md. Zahidunnabi, Mariko Watanabe, Kazuo Terashima, et al.. (2005). Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor‐κB activity in unconditioned NOD/SCID/γcnull mice. Cancer Science. 96(8). 466–473. 14 indexed citations
14.
Ohsugi, Takeo, Ryouichi Horie, Toshio Kumasaka, et al.. (2005). In vivo antitumor activity of the NF-κB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia. Carcinogenesis. 26(8). 1382–1388. 53 indexed citations
15.
Higuchi, Masaya, Takehiro Matsuda, Naoki Mori, et al.. (2005). Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-κB activation. Retrovirology. 2(1). 29–29. 33 indexed citations
16.
Ohsugi, Takeo, Kazunari Yamaguchi, Toshio Kumasaka, et al.. (2004). Rapid tumor death model for evaluation of new therapeutic agents for adult T-cell leukemia. Laboratory Investigation. 84(2). 263–266. 9 indexed citations
17.
Watanabe, Mariko, Yuji Ogawa, Kinji Ito, et al.. (2003). AP-1 Mediated Relief of Repressive Activity of the CD30 Promoter Microsatellite in Hodgkin and Reed-Sternberg Cells. American Journal Of Pathology. 163(2). 633–641. 41 indexed citations
18.
Horie, Ryouichi, Takuro Watanabe, Kinji Ito, et al.. (2002). Cytoplasmic Aggregation of TRAF2 and TRAF5 Proteins in the Hodgkin-Reed-Sternberg Cells. American Journal Of Pathology. 160(5). 1647–1654. 50 indexed citations
19.
Horie, Ryouichi, Yutaka Yatomi, Tomoko Wakabayashi, et al.. (1999). Primary Gastric T-cell Lymphomas: Report of Two Cases and a Review of the Literature. Japanese Journal of Clinical Oncology. 29(3). 171–178. 17 indexed citations
20.
Horie, Ryouichi, Valter Gattei, Kinji Ito, et al.. (1999). Frequent Expression of the Variant CD30 in Human Malignant Myeloid and Lymphoid Neoplasms. American Journal Of Pathology. 155(6). 2029–2041. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaaki Higashihara Breakdown of academic impact, for papers by Junichi Kameoka Breakdown of academic impact, for papers by Mitsuru Tsudo Breakdown of academic impact, for papers by Shigeki Shimizu Breakdown of academic impact, for papers by Angela Gradilone Breakdown of academic impact, for papers by Philippe Ruminy Breakdown of academic impact, for papers by Richard Gedrich Breakdown of academic impact, for papers by Kensuke Kojima Breakdown of academic impact, for papers by A F Gazdar Breakdown of academic impact, for papers by M Stetler-Stevenson
Rankless by CCL
2026